Ken Moseley, Senior VP and General Counsel at BELLICUM PHARMACEUTICALS, INC (BLCM), sold 15,000 shares at $21.33 ($309K) on 2015-07-01, disclosed to the SEC on 2015-07-06.
Scheduled sale ($309k) by Senior VP and General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.60 | 14,550 | $300K | 96.9% |
| 2 | $21.33 | 450 | $10K | 3.1% |
| Total | $20.62 avg | 15,000 | $309K | 100% |
| Filing → |
| BLCM | SELL | 2016-09-20 | $70K | — | Filing → |
| BLCM | SELL | 2016-08-17 | $20K | — | Filing → |
| BLCM | SELL | 2016-06-06 | $195K | — | Filing → |